Showing 1,381 - 1,400 results of 2,092 for search '"chemotherapy"', query time: 0.05s Refine Results
  1. 1381

    Do Pathologic Fractures in Long Bone Following Bony Malignancy Increase the Risk of Venous Thromboembolism? A Comparative Study by Sanjay Kumar Rai, Tej Pratap Gupta, Bhavya Sirohi, Surbhi Rajauria, Nitish Khandelwal

    Published 2024-01-01
    “…This risk of developing DVT is increased much fold in the presence of metastasis, chemotherapy, radiotherapy, fracture fixation, and arthroplasty.…”
    Get full text
    Article
  2. 1382

    PTLD Burkitt Lymphoma in a Patient with Remote Lymphomatoid Granulomatosis by A. Stravodimou, A. Cairoli, T. Rausch, R. Du Pasquier, P. Michel

    Published 2012-01-01
    “…With careful reduction of the immunosuppression after the first manifestation and with the use of chemotherapy combined with radiotherapy after the second manifestation, our patient showed complete disappearance of neurologic symptoms and she is clinically well with good kidney function. …”
    Get full text
    Article
  3. 1383

    Cotrimoxazole-Resistant Escherichia coli Bacteremia in Neutropenic Patients at a Regional Oncology Hospital by Daniel B Gregson, Anne G Matlow, Andrew E Simor, Peter G Tuffnell, Donald E Low, Ronald Feld, James E Brunton

    Published 1992-01-01
    “…In a regional oncology hospital using cotrimoxazole (trimethoprim-sulphamethoxazole) prophylaxis during chemotherapy-induced neutropenia, a single strain of Escherichia coli (indole negative) caused 15 of 27 episodes of Gram-negative rod bacteremia in 1987, and four of 32 such episodes in 1988. …”
    Get full text
    Article
  4. 1384

    The Potential Impact of HNRNPA2B1 on Human Cancers Prognosis and Immune Microenvironment by Tao Huang, Gang Zhu, Fan Chen

    Published 2024-01-01
    “…HNRNPA2B1 expression was also closely linked to TMB, MSI, tumor stemness, and chemotherapy response. HNRNPA2B1 plays a significant role in the TME and is involved in the regulation of novel immunotherapies. …”
    Get full text
    Article
  5. 1385

    Primary Signet-Ring Cell Adenocarcinoma of the Urinary Bladder Treated with Partial Cystectomy: A Case Report and Review of the Literature by Umesh Jayarajah, D. M. Hilary Fernando, Kasun Bandara Herath, M. V. Chandu de Silva, S. A. S. Goonewardena

    Published 2017-01-01
    “…Primary signet-ring cell carcinoma is a variant of adenocarcinoma which is extremely rare, associated with poor prognosis and generally found to be resistant to chemotherapy and radiotherapy. We report a case of primary signet-ring cell carcinoma of the bladder which was successfully treated with partial cystectomy. …”
    Get full text
    Article
  6. 1386

    Primary Ewing’s Sarcoma of the Spine in a Two-Year-Old Boy by Ali J. Electricwala, Jaffer T. Electricwala

    Published 2016-01-01
    “…The child was then referred to a specialized oncotherapy centre for further treatment, radiation, and chemotherapy. To the best of our knowledge, we are the first to report primary ES of the spine at the age of two years.…”
    Get full text
    Article
  7. 1387

    First Reported Case of Endoscopic Ultrasound-Guided Core Biopsy Yielding Diagnosis of Primary Adrenal Leiomyosarcoma by Shaunak R. Mulani, Patrick Stoner, Alexander Schlachterman, Hans K. Ghayee, Li Lu, Anand Gupte

    Published 2018-01-01
    “…The patient was treated with chemotherapy with palliative radiation. This case demonstrates the utility of EUS-FNA or CB as modalities that can aid in the diagnosis of adrenal lesions in specific circumstances.…”
    Get full text
    Article
  8. 1388

    Susceptibility Profiles of Mycobacterium ulcerans Isolates to Streptomycin and Rifampicin in Two Districts of the Eastern Region of Ghana by Enid Owusu, Mercy Jemima Newman, Nana Konama Kotey, Amos Akumwena, Elizabeth Bannerman

    Published 2016-01-01
    “…Drug resistance is a major challenge in antibiotic chemotherapy. Assessing resistance profiles of pathogens constitutes an essential surveillance tool in the epidemiology and control of infectious diseases, including Buruli ulcer (BU) disease. …”
    Get full text
    Article
  9. 1389

    Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features by Abdullah M. Khan, Jameel Muzaffar, Hermant Murthy, John R. Wingard, Jan S. Moreb

    Published 2018-01-01
    “…Patients develop sALL after median of 32.5 months (range, 20–84) from being on lenalidomide or thalidomide maintenance, often presenting with cytopenias, display low tolerance to chemotherapy, but remission can often be achieved.…”
    Get full text
    Article
  10. 1390

    Primary Pericardial Sarcoma with Right Atrial Invasion and Multiple Bilateral Pulmonary Metastases in a Patient with Hereditary Nonpolyposis Colorectal Cancer by Eugene Wong, Lawrence J. Oh, Kazi Nahar, Adrian Lee, Stephen Clarke

    Published 2016-01-01
    “…The patient was then started on chemotherapy; however, progression soon occurred and the patient died within 4 months, suggesting there is urgent need for efficacious treatments for sarcomatous lesions.…”
    Get full text
    Article
  11. 1391

    Multidisciplinary Management of Soft Tissue Sarcoma by Lukas M. Nystrom, Nickolas B. Reimer, John D. Reith, Long Dang, Robert A. Zlotecki, Mark T. Scarborough, C. Parker Gibbs

    Published 2013-01-01
    “…Currently, the role of chemotherapy is not well defined and this treatment is typically reserved for patients with metastatic or recurrent disease and for certain histologic subtypes. …”
    Get full text
    Article
  12. 1392

    RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER by A. A. Kostin, A. G. Muradyan, A. O. Tolkachev, S. V. Popov

    Published 2017-12-01
    “…Currently, there are six effective methods of treatment of metastatic castration-refractory prostate cancer (mCRPC): effects on androgenic stimulation (abiraterone acetate, enzalutamide); chemotherapy with drugs from the taxane group (docetaxel, cabazitaxel); immunotherapy (Sipuleucel-T), radionuclide therapy with Radium-223 chloride (Ksofigo®). 223Ra is a tropic to bone tissue alpha emitter, which, due to its high linear energy transfer and short transmission distance, provides an enhanced localized antitumor effect due to higher energy delivery. …”
    Get full text
    Article
  13. 1393

    Late Recurrence in Ovarian Dysgerminoma Presenting as a Primary Retroperitoneal Tumor: A Case Report and Review of the Literature by Yuichiro Sato, Tohru Hayashi, Hidetaka Yamamoto, Ichiro Niina, Naoya Kuroki, Takeshi Iwamura, Junji Onishi

    Published 2020-01-01
    “…The patient was treated with bleomycin, etoposide, and cisplatin chemotherapy. This case demonstrates the difficulties that may be encountered in the differential diagnosis of a retroperitoneal mass and underlines the necessity for understanding a patient’s clinical history.…”
    Get full text
    Article
  14. 1394

    ANTIBIOTIC LOCK THERAPY FOR PORT CATHETER-RELATED INFECTIONS OF CHILDREN WITH ACUTE LEUKEMIA by Burçin Kurtipek, Ayça Koca Yozgat, Saliha Kanık Yüksek, Dilek Kaçar, Turan Bayhan, Dilek Gürlek Gökçebay, Aslınur Özkaya Parlak, Neşe Yaralı

    Published 2024-08-01
    “… Background: Port catheters facilitate the administration of chemotherapy, antibiotics, blood products, fluid and parenteral nutritional support to pediatric patients with hematological malignancies. …”
    Get full text
    Article
  15. 1395

    Development of Thermoresponsive Composite Hydrogel Loaded with Indocyanine Green and Camptothecin for Photochemotherapy of Skin Cancer After Surgery by Yu-Hsiang Lee, Chieh-Lin Chung

    Published 2025-01-01
    “…Although regimens such as chemotherapy and/or immunotherapy are often administered following surgical treatments, the patients may suffer from severe side effects, drug resistance, and/or high cost during treatments, indicating that the development of an effective and safe modality for skin cancer after surgery is still highly demanded nowadays. …”
    Get full text
    Article
  16. 1396

    A Prospective Study Assessing Tumour Response, Survival, and Palliative Care Outcomes in Patients with HIV-Related Kaposi's Sarcoma at Queen Elizabeth Central Hospital, Blantyre, M... by H. Francis, M. J. Bates, L. Kalilani

    Published 2012-01-01
    “…Tumour response, survival, and chemotherapy-related toxicities were documented. Palliative care outcomes were assessed using the African Palliative Care Association (APCA) Palliative Outcome Scale (POS). …”
    Get full text
    Article
  17. 1397

    Microenvironment Elements Involved in the Development of Pancreatic Cancer Tumor by Katarzyna Gardian, Sława Janczewska, Marek Durlik

    Published 2012-01-01
    “…The surgical intervention remains main possibility of treatment because chemotherapy and radiotherapy has a minimal impact on long-term survival. …”
    Get full text
    Article
  18. 1398

    Social role performance and self-identity among breast cancer patients in Lagos, Nigeria by Samuel Ojima Adejoh, Deborah Tolulope Esan, Adeola Adejayan

    Published 2018-07-01
    “…The population study comprised of women who were diagnosed with breast cancer, had undergone surgery, and were currently or recently receiving chemotherapy and/or radiotherapy at private hospitals in Ikeja, capital of Lagos State, Nigeria, from December 2015 to March 2016. …”
    Get full text
    Article
  19. 1399

    Integrated bioinformatic approach of Balur therapy for breast cancer subtypes by Aristyani Sherry, Subagjo Saraswati, Rahayu Tintrim, Sumitro Sutiman B.

    Published 2025-01-01
    “…From these target genes, 7 Balur compounds had higher binding energy than chemotherapy compounds when they docked with hub genes from each subtype. …”
    Get full text
    Article
  20. 1400

    Invasive Aspergillosis in a Patient with Stage III (or 3a or 3b) Non-Small-Cell Lung Cancer Treated with Durvalumab by Ashish Gupta, Aung Tun, Katy Ticona, Aam Baqui, Elizabeth Guevara

    Published 2019-01-01
    “…He had completed six cycles of chemotherapy with paclitaxel and carboplatin and four cycles of immunotherapy with durvalumab 13 days before his emergency hospital admission. …”
    Get full text
    Article